vs
OUTFRONT Media Inc.（OUT）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是OUTFRONT Media Inc.的1.5倍（$772.1M vs $513.3M），OUTFRONT Media Inc.净利率更高（18.9% vs 12.7%，领先6.1%），Revvity同比增速更快（5.9% vs 4.1%），Revvity自由现金流更多（$161.8M vs $93.3M），过去两年OUTFRONT Media Inc.的营收复合增速更高（12.1% vs 9.0%）
OUTFRONT Media Inc.是一家美国广告企业，业务覆盖美国本土，由首席执行官Nick Brien领导美洲区业务，核心经营广告牌及公共交通展示广告两大业务板块，是户外广告领域的重要参与者。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
OUT vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.5倍
$513.3M
营收增速更快
RVTY
高出1.8%
4.1%
净利率更高
OUT
高出6.1%
12.7%
自由现金流更多
RVTY
多$68.5M
$93.3M
两年增速更快
OUT
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $513.3M | $772.1M |
| 净利润 | $96.8M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 26.0% | 14.5% |
| 净利率 | 18.9% | 12.7% |
| 营收同比 | 4.1% | 5.9% |
| 净利润同比 | 30.8% | 3.9% |
| 每股收益（稀释后） | $0.57 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OUTRVTY
| Q4 25 | $513.3M | $772.1M | ||
| Q3 25 | $467.5M | $698.9M | ||
| Q2 25 | $460.2M | $720.3M | ||
| Q1 25 | $390.7M | $664.8M | ||
| Q4 24 | $493.2M | $729.4M | ||
| Q3 24 | $451.9M | $684.0M | ||
| Q2 24 | $477.3M | $691.7M | ||
| Q1 24 | $408.5M | $649.9M |
净利润OUTRVTY
| Q4 25 | $96.8M | $98.4M | ||
| Q3 25 | $51.3M | $46.7M | ||
| Q2 25 | $19.5M | $53.9M | ||
| Q1 25 | $-20.6M | $42.2M | ||
| Q4 24 | $74.0M | $94.6M | ||
| Q3 24 | $34.6M | $94.4M | ||
| Q2 24 | $176.8M | $55.4M | ||
| Q1 24 | $-27.2M | $26.0M |
毛利率OUTRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率OUTRVTY
| Q4 25 | 26.0% | 14.5% | ||
| Q3 25 | 19.2% | 11.7% | ||
| Q2 25 | 12.2% | 12.6% | ||
| Q1 25 | 3.6% | 10.9% | ||
| Q4 24 | 22.5% | 16.3% | ||
| Q3 24 | 15.8% | 14.3% | ||
| Q2 24 | 48.0% | 12.4% | ||
| Q1 24 | 3.4% | 6.8% |
净利率OUTRVTY
| Q4 25 | 18.9% | 12.7% | ||
| Q3 25 | 11.0% | 6.7% | ||
| Q2 25 | 4.2% | 7.5% | ||
| Q1 25 | -5.3% | 6.4% | ||
| Q4 24 | 15.0% | 13.0% | ||
| Q3 24 | 7.7% | 13.8% | ||
| Q2 24 | 37.0% | 8.0% | ||
| Q1 24 | -6.7% | 4.0% |
每股收益（稀释后）OUTRVTY
| Q4 25 | $0.57 | $0.86 | ||
| Q3 25 | $0.29 | $0.40 | ||
| Q2 25 | $0.10 | $0.46 | ||
| Q1 25 | $-0.14 | $0.35 | ||
| Q4 24 | $0.49 | $0.77 | ||
| Q3 24 | $0.19 | $0.77 | ||
| Q2 24 | $1.01 | $0.45 | ||
| Q1 24 | $-0.18 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $99.9M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $710.4M | $7.3B |
| 总资产 | $5.3B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OUTRVTY
| Q4 25 | $99.9M | $919.9M | ||
| Q3 25 | $63.0M | $931.4M | ||
| Q2 25 | $28.5M | $991.8M | ||
| Q1 25 | $30.5M | $1.1B | ||
| Q4 24 | $46.9M | $1.2B | ||
| Q3 24 | $28.0M | $1.2B | ||
| Q2 24 | $49.6M | $2.0B | ||
| Q1 24 | $42.4M | $1.7B |
股东权益OUTRVTY
| Q4 25 | $710.4M | $7.3B | ||
| Q3 25 | $542.6M | $7.4B | ||
| Q2 25 | $539.1M | $7.6B | ||
| Q1 25 | $566.9M | $7.6B | ||
| Q4 24 | $649.0M | $7.7B | ||
| Q3 24 | $618.2M | $7.9B | ||
| Q2 24 | $664.9M | $7.9B | ||
| Q1 24 | $524.2M | $7.8B |
总资产OUTRVTY
| Q4 25 | $5.3B | $12.2B | ||
| Q3 25 | $5.2B | $12.1B | ||
| Q2 25 | $5.1B | $12.4B | ||
| Q1 25 | $5.1B | $12.4B | ||
| Q4 24 | $5.2B | $12.4B | ||
| Q3 24 | $5.2B | $12.8B | ||
| Q2 24 | $5.3B | $13.4B | ||
| Q1 24 | $5.5B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $118.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $93.3M | $161.8M |
| 自由现金流率自由现金流/营收 | 18.2% | 21.0% |
| 资本支出强度资本支出/营收 | 4.8% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.22× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $218.8M | $509.4M |
8季度趋势，按日历期对齐
经营现金流OUTRVTY
| Q4 25 | $118.1M | $182.0M | ||
| Q3 25 | $88.8M | $138.5M | ||
| Q2 25 | $67.1M | $134.3M | ||
| Q1 25 | $33.6M | $128.2M | ||
| Q4 24 | $124.5M | $174.2M | ||
| Q3 24 | $73.1M | $147.9M | ||
| Q2 24 | $71.0M | $158.6M | ||
| Q1 24 | $30.6M | $147.6M |
自由现金流OUTRVTY
| Q4 25 | $93.3M | $161.8M | ||
| Q3 25 | $67.7M | $120.0M | ||
| Q2 25 | $41.4M | $115.5M | ||
| Q1 25 | $16.4M | $112.2M | ||
| Q4 24 | $106.3M | $149.8M | ||
| Q3 24 | $55.5M | $125.6M | ||
| Q2 24 | $47.1M | $136.6M | ||
| Q1 24 | $12.2M | $129.7M |
自由现金流率OUTRVTY
| Q4 25 | 18.2% | 21.0% | ||
| Q3 25 | 14.5% | 17.2% | ||
| Q2 25 | 9.0% | 16.0% | ||
| Q1 25 | 4.2% | 16.9% | ||
| Q4 24 | 21.6% | 20.5% | ||
| Q3 24 | 12.3% | 18.4% | ||
| Q2 24 | 9.9% | 19.7% | ||
| Q1 24 | 3.0% | 20.0% |
资本支出强度OUTRVTY
| Q4 25 | 4.8% | 2.6% | ||
| Q3 25 | 4.5% | 2.6% | ||
| Q2 25 | 5.6% | 2.6% | ||
| Q1 25 | 4.4% | 2.4% | ||
| Q4 24 | 3.7% | 3.4% | ||
| Q3 24 | 3.9% | 3.3% | ||
| Q2 24 | 5.0% | 3.2% | ||
| Q1 24 | 4.5% | 2.7% |
现金转化率OUTRVTY
| Q4 25 | 1.22× | 1.85× | ||
| Q3 25 | 1.73× | 2.97× | ||
| Q2 25 | 3.44× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 1.68× | 1.84× | ||
| Q3 24 | 2.11× | 1.57× | ||
| Q2 24 | 0.40× | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OUT
| Static Displays | $236.3M | 46% |
| Other | $134.8M | 26% |
| Digital Displays | $125.3M | 24% |
| Other Revenues | $1.9M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
